• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

托吡酯对酒精使用影响的生物行为机制:一项结合实验室评估与生态瞬时评估的调查

Biobehavioral mechanisms of topiramate's effects on alcohol use: an investigation pairing laboratory and ecological momentary assessments.

作者信息

Miranda Robert, MacKillop James, Treloar Hayley, Blanchard Alexander, Tidey Jennifer W, Swift Robert M, Chun Thomas, Rohsenow Damaris J, Monti Peter M

机构信息

Center for Alcohol and Addiction Studies, Brown University, Providence, RI, USA.

出版信息

Addict Biol. 2016 Jan;21(1):171-82. doi: 10.1111/adb.12192. Epub 2014 Oct 29.

DOI:10.1111/adb.12192
PMID:25353306
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4414660/
Abstract

Topiramate reduces drinking, but little is known about the mechanisms that precipitate this effect. This double-blind randomized placebo-controlled study assessed the putative mechanisms by which topiramate reduces alcohol use among 96 adult non-treatment-seeking heavy drinkers in a laboratory-based alcohol cue reactivity assessment and in the natural environment using ecological momentary assessment methods. Topiramate reduced the quantity of alcohol heavy drinkers consumed on drinking days and reduced craving while participants were drinking but did not affect craving outside of drinking episodes in either the laboratory or in the natural environment. Topiramate did not alter the stimulant or sedative effects of alcohol ingestion during the ascending limb of the blood alcohol curve. A direct test of putative mechanisms of action using multilevel structural equation mediation models showed that topiramate reduced drinking indirectly by blunting alcohol-induced craving. These findings provide the first real-time prospective evidence that topiramate reduces drinking by reducing alcohol's priming effects on craving and highlight the importance of craving as an important treatment target of pharmacotherapy for alcoholism.

摘要

托吡酯可减少饮酒量,但对于引发这一效果的机制却知之甚少。这项双盲随机安慰剂对照研究,在基于实验室的酒精线索反应性评估以及使用生态瞬时评估方法的自然环境中,评估了托吡酯减少96名未寻求治疗的成年重度饮酒者酒精使用量的假定机制。托吡酯减少了重度饮酒者在饮酒日的饮酒量,并在参与者饮酒时减少了渴望感,但在实验室或自然环境中,对饮酒时段之外的渴望感并无影响。在血酒精曲线上升阶段,托吡酯并未改变酒精摄入的兴奋或镇静作用。使用多水平结构方程中介模型对假定作用机制进行的直接测试表明,托吡酯通过减弱酒精诱发的渴望感间接减少了饮酒量。这些发现提供了首个实时前瞻性证据,即托吡酯通过减少酒精对渴望感的启动效应来减少饮酒量,并突出了渴望感作为酒精中毒药物治疗重要靶点的重要性。

相似文献

1
Biobehavioral mechanisms of topiramate's effects on alcohol use: an investigation pairing laboratory and ecological momentary assessments.托吡酯对酒精使用影响的生物行为机制:一项结合实验室评估与生态瞬时评估的调查
Addict Biol. 2016 Jan;21(1):171-82. doi: 10.1111/adb.12192. Epub 2014 Oct 29.
2
Effects of topiramate on urge to drink and the subjective effects of alcohol: a preliminary laboratory study.托吡酯对饮酒冲动及酒精主观效应的影响:一项初步实验室研究。
Alcohol Clin Exp Res. 2008 Mar;32(3):489-97. doi: 10.1111/j.1530-0277.2007.00592.x. Epub 2008 Jan 22.
3
Effects of topiramate on neural responses to alcohol cues in treatment-seeking individuals with alcohol use disorder: preliminary findings from a randomized, placebo-controlled trial.治疗酒精使用障碍患者的托吡酯对酒精线索的神经反应的影响:一项随机、安慰剂对照试验的初步发现。
Neuropsychopharmacology. 2021 Jul;46(8):1414-1420. doi: 10.1038/s41386-021-00968-w. Epub 2021 Feb 8.
4
Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol-dependent individuals: a randomized controlled trial.口服托吡酯可减轻饮酒后果并改善酒精依赖者的生活质量:一项随机对照试验。
Arch Gen Psychiatry. 2004 Sep;61(9):905-12. doi: 10.1001/archpsyc.61.9.905.
5
GRIK1 genotype moderates topiramate's effects on daily drinking level, expectations of alcohol's positive effects and desire to drink.谷氨酸受体离子型钾离子通道亚型1(GRIK1)基因类型可调节托吡酯对每日饮酒量、对酒精积极作用的预期以及饮酒欲望的影响。
Int J Neuropsychopharmacol. 2014 Oct;17(10):1549-56. doi: 10.1017/S1461145714000510. Epub 2014 Apr 30.
6
Topiramate treatment of alcohol use disorder in veterans with posttraumatic stress disorder: a randomized controlled pilot trial.托吡酯治疗创伤后应激障碍退伍军人酒精使用障碍:一项随机对照试验。
Alcohol Clin Exp Res. 2014 Aug;38(8):2169-77. doi: 10.1111/acer.12496. Epub 2014 Aug 4.
7
Zonisamide, topiramate, and levetiracetam: efficacy and neuropsychological effects in alcohol use disorders.唑尼沙胺、托吡酯和左乙拉西坦:在酒精使用障碍中的疗效及神经心理学效应
J Clin Psychopharmacol. 2015 Feb;35(1):34-42. doi: 10.1097/JCP.0000000000000246.
8
Comparing and Combining Topiramate and Aripiprazole on Alcohol-Related Outcomes in a Human Laboratory Study.在一项人体实验室研究中比较和联合使用托吡酯与阿立哌唑对酒精相关结果的影响
Alcohol Alcohol. 2018 May 1;53(3):268-276. doi: 10.1093/alcalc/agx108.
9
Balancing risk and benefit in heavy drinkers treated with topiramate: implications for personalized care.托吡酯治疗重度饮酒者时风险与获益的权衡:对个性化治疗的启示
J Clin Psychiatry. 2016 Mar;77(3):e278-82. doi: 10.4088/JCP.15m10053.
10
A randomized pilot trial of topiramate for alcohol use disorder in veterans with traumatic brain injury: Effects on alcohol use, cognition, and post-concussive symptoms.一项针对创伤性脑损伤退伍军人酒精使用障碍的托吡酯随机先导试验:对酒精使用、认知和脑震荡后症状的影响。
Drug Alcohol Depend. 2020 Sep 1;214:108149. doi: 10.1016/j.drugalcdep.2020.108149. Epub 2020 Jul 2.

引用本文的文献

1
The neural and psychophysiological effects of cannabidiol in youth with alcohol use disorder: A randomized controlled clinical trial.大麻二酚对患有酒精使用障碍的青少年的神经和心理生理影响:一项随机对照临床试验。
Neuropsychopharmacology. 2025 Jun 11. doi: 10.1038/s41386-025-02141-z.
2
Preliminary effects of oral ANS-6637, an ALDH2 inhibitor, on cue-induced craving, safety and alcohol consumption among adults with alcohol use disorder: a proof-of-concept, randomized, human laboratory trial.口服醛脱氢酶2(ALDH2)抑制剂ANS-6637对酒精使用障碍成年人线索诱导的渴望、安全性和酒精消费的初步影响:一项概念验证性随机人体实验室试验。
Alcohol Alcohol. 2025 Jan 19;60(2). doi: 10.1093/alcalc/agaf001.
3

本文引用的文献

1
GRIK1 genotype moderates topiramate's effects on daily drinking level, expectations of alcohol's positive effects and desire to drink.谷氨酸受体离子型钾离子通道亚型1(GRIK1)基因类型可调节托吡酯对每日饮酒量、对酒精积极作用的预期以及饮酒欲望的影响。
Int J Neuropsychopharmacol. 2014 Oct;17(10):1549-56. doi: 10.1017/S1461145714000510. Epub 2014 Apr 30.
2
Characterizing subjective responses to alcohol among adolescent problem drinkers.描述青少年问题饮酒者对酒精的主观反应。
J Abnorm Psychol. 2014 Feb;123(1):117-29. doi: 10.1037/a0035328.
3
Topiramate treatment for heavy drinkers: moderation by a GRIK1 polymorphism.
Examining Caregiver Practices During Adolescent Outpatient Alcohol Use and Co-Occurring Mental Health Treatment: Protocol for a Dyadic Ecological Momentary Assessment Study.
青少年门诊酒精使用及并发心理健康治疗期间的照护者行为研究:一项二元生态瞬时评估研究方案
JMIR Res Protoc. 2024 Dec 20;13:e63399. doi: 10.2196/63399.
4
Design and rationale for a randomized clinical trial testing the efficacy of a lifestyle physical activity intervention for people with HIV and engaged in unhealthy drinking.设计和原理:一项随机临床试验,旨在测试针对 HIV 感染者和不健康饮酒者的生活方式体力活动干预的疗效。
Contemp Clin Trials. 2024 Sep;144:107632. doi: 10.1016/j.cct.2024.107632. Epub 2024 Jul 15.
5
Endpoints for Pharmacotherapy Trials for Alcohol Use Disorder.酒精使用障碍药物治疗试验的终点。
Pharmaceut Med. 2024 Jul;38(4):291-302. doi: 10.1007/s40290-024-00526-x. Epub 2024 Jul 5.
6
Beyond mediators: A critical review and methodological path forward for studying mechanisms in alcohol use treatment research.超越中介因素:酒精使用治疗研究中机制研究的批判性综述与方法学前进路径
Alcohol Clin Exp Res (Hoboken). 2024 Feb;48(2):215-229. doi: 10.1111/acer.15242. Epub 2023 Dec 27.
7
Does sleep relate to next-day cannabis use during treatment? Findings from an adolescent and young adult motivational enhancement and cognitive behavioral therapy plus topiramate intervention.睡眠与治疗期间次日大麻使用有关吗?一项针对青少年和年轻成年人的动机增强和认知行为治疗加托吡酯干预的研究结果。
Drug Alcohol Depend. 2023 Dec 1;253:111006. doi: 10.1016/j.drugalcdep.2023.111006. Epub 2023 Oct 23.
8
Testing pharmacotherapies for alcohol use disorder with cue exposure paradigms: A systematic review and quantitative synthesis of human laboratory trial methodology.使用线索暴露范式测试酒精使用障碍的药物疗法:人类实验室试验方法的系统评价与定量综合
Alcohol Clin Exp Res (Hoboken). 2023 Sep;47(9):1629-1645. doi: 10.1111/acer.15143. Epub 2023 Jul 23.
9
The neurobiological markers of acute alcohol's subjective effects in humans.人类急性酒精主观效应的神经生物学标志物。
Neuropsychopharmacology. 2022 Nov;47(12):2101-2110. doi: 10.1038/s41386-022-01354-w. Epub 2022 Jun 14.
10
SUBSTANCE USE AND ADDICTION AFFECT MORE THAN THE BRAIN: THE PROMISE OF NEUROCARDIAC INTERVENTIONS.物质使用与成瘾的影响不止于大脑:神经心脏干预的前景。
Curr Addict Rep. 2021 Sep;8(3):431-439. doi: 10.1007/s40429-021-00379-3. Epub 2021 Aug 9.
托吡酯治疗重度饮酒者:由 GRIK1 多态性调节。
Am J Psychiatry. 2014 Apr;171(4):445-52. doi: 10.1176/appi.ajp.2013.13081014.
4
Alcohol craving in adolescents: bridging the laboratory and natural environment.青少年的酒精渴望:连接实验室与自然环境
Psychopharmacology (Berl). 2014 Apr;231(8):1841-51. doi: 10.1007/s00213-013-3372-6. Epub 2013 Dec 22.
5
Novel metabolic drugs and blood pressure: implications for the treatment of obese hypertensive patients?新型代谢药物与血压:对肥胖高血压患者治疗的影响?
Curr Hypertens Rep. 2013 Oct;15(5):470-4. doi: 10.1007/s11906-013-0374-z.
6
Topiramate treatment for alcoholic outpatients recently receiving residential treatment programs: a 12-week, randomized, placebo-controlled trial.托吡酯治疗最近接受住院治疗的酒精性门诊患者:一项为期 12 周、随机、安慰剂对照试验。
Drug Alcohol Depend. 2013 Dec 1;133(2):440-6. doi: 10.1016/j.drugalcdep.2013.06.032. Epub 2013 Jul 29.
7
Effects of naltrexone on adolescent alcohol cue reactivity and sensitivity: an initial randomized trial.纳曲酮对青少年酒精线索反应性和敏感性的影响:一项初步随机试验。
Addict Biol. 2014 Sep;19(5):941-54. doi: 10.1111/adb.12050. Epub 2013 Mar 13.
8
Responses to alcohol and cigarette use during ecologically assessed drinking episodes.对生态评估饮酒期间饮酒和吸烟的反应。
Psychopharmacology (Berl). 2012 Oct;223(3):331-44. doi: 10.1007/s00213-012-2721-1. Epub 2012 Apr 27.
9
Treatment of alcohol dependence with low-dose topiramate: an open-label controlled study.低剂量托吡酯治疗酒精依赖:一项开放标签对照研究。
BMC Psychiatry. 2011 Mar 14;11:41. doi: 10.1186/1471-244X-11-41.
10
A general multilevel SEM framework for assessing multilevel mediation.一种用于评估多层次中介的通用多层次 SEM 框架。
Psychol Methods. 2010 Sep;15(3):209-33. doi: 10.1037/a0020141.